Gemcitabine-Induced Acute Coronary Syndrome: A Case Report

被引:9
作者
Ozturk, Banu [1 ]
Tacoy, Gulten [2 ]
Coskun, Ugur [1 ]
Yaman, Emel [1 ]
Sahin, Giray [1 ]
Buyukberber, Suleyman [1 ]
Yildiz, Ramazan [1 ]
Kaya, Ali O. [1 ]
Topal, Salih [2 ]
Ozdemir, Murat [2 ]
Benekli, Mustafa [1 ]
机构
[1] Gazi Univ, Sch Med, Dept Med Oncol, TR-06500 Ankara, Turkey
[2] Gazi Univ, Sch Med, Dept Cardiol, TR-06500 Ankara, Turkey
关键词
Gemcitabine; Coronary syndrome; Left bundle-branch block; ACUTE MYOCARDIAL-INFARCTION; PHASE-II; 5-FLUOROURACIL; THERAPY; CANCER;
D O I
10.1159/000163051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To report a case of metastatic leiomyosarcoma, in which a patient developed chest pain accompanied by acute left bundle-branch block (LBBB) after gemcitabine infusion. Clinical Presentation and Intervention: A 59-year-old woman admitted with bilateral pulmonary nodules had classic risk factors for coronary heart disease and coronary stenosis as demonstrated by previous coronary angiography. She was treated with gemcitabine infusion, and 30 min later she experienced severe chest pain accompanied by acute LBBB confirmed by ECG. We suspected gemcitabine-induced coronary vasospasm exacerbated by the preexisting coronary artery disease as the cause of the acute coronary syndrome. The patient was subsequently treated with antianginal therapy and percutaneous coronary intervention. Her chest pain resolved and LBBB disappeared. She was discharged 2 days later without any further cardiac events. No additional cancer therapy was given and she died 5 months later, due to disease progression. Conclusion: This case showed that chemotherapeutic agents must be administered with intensive cardiac monitoring especially in patients with cardiac disease and well-known risk factors to prevent the development of cardiac complications, despite an agent not being known to be 'cardiotoxic'. Copyright (C) 2008 S. Karger AG, Basel
引用
收藏
页码:76 / 80
页数:5
相关论文
共 50 条
  • [1] Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: A case report and review of the literature
    Rajasekhar, Anita
    George, Thomas J., Jr.
    ONCOLOGIST, 2007, 12 (11) : 1332 - 1335
  • [2] Gemcitabine-induced haemolytic uremic syndrome, although infrequent, can it be prevented: A case report and review of literatureN
    Cidon, Esther U.
    Martinez, Pilar A.
    Hickish, Tamas
    WORLD JOURNAL OF CLINICAL CASES, 2018, 6 (12) : 531 - 537
  • [3] Gemcitabine-Induced Hemolytic Uremic Syndrome in Pancreatic Cancer: A Case Report and Review of the Literature
    Lee, Hye Won
    Chung, Moon Jae
    Kang, Huapyong
    Choi, Heun
    Choi, Youn Jeong
    Lee, Kyung Joo
    Lee, Seung Woo
    Han, Seung Hyuk
    Kim, Jin Seok
    Song, Si Young
    GUT AND LIVER, 2014, 8 (01) : 109 - 112
  • [4] Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report
    Fenocchio, Elisabetta
    Depetris, Ilaria
    Campanella, Delia
    Garetto, Lucia
    Schianca, Fabrizio Carnevale
    Galizia, Danilo
    Grignani, Giovanni
    Aglietta, Massimo
    Leone, Francesco
    BMC CANCER, 2016, 16
  • [5] Clinical efficacy of eculizumab as treatment of gemcitabine-induced thrombotic microangiopathy: A case report
    Rogier, T.
    Gerfaud-Valentin, M.
    Pouteil-Noble, C.
    Taleb, A.
    Guillet, M.
    Noel, A.
    Broussolle, C.
    Seve, P.
    REVUE DE MEDECINE INTERNE, 2016, 37 (10): : 701 - 704
  • [6] Gemcitabine-induced haemolytic uraemic syndrome in pancreatic adenocarcinoma
    Das, Adarsh
    Dean, Andrew
    Clay, Tim
    BMJ CASE REPORTS, 2019, 12 (04)
  • [7] Gemcitabine-induced cardiomyopathy: A case report and review of the literature
    Khan M.F.
    Gottesman S.
    Boyella R.
    Juneman E.
    Journal of Medical Case Reports, 8 (1)
  • [8] Gemcitabine-induced pseudocellulitis: a case report and review of the literature
    Bami, H.
    Goodman, C.
    Boldt, G.
    Vincent, M.
    CURRENT ONCOLOGY, 2019, 26 (05) : E703 - E706
  • [9] Gemcitabine-induced radiation recall dermatitis: Case report
    Bar-Sela, G
    Beny, A
    Bergman, R
    Kuten, A
    TUMORI, 2001, 87 (06) : 428 - 430
  • [10] Favorable outcome of gemcitabine-induced acute respiratory distress syndrome
    Bonnichon, A.
    Vedrine, L.
    Aletti, M.
    Le Moulec, S.
    Borne, M.
    Margery, J.
    Bauduceau, O.
    Fayolle, M.
    Ceccaldi, B.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2007, 63 (06) : 379 - 383